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Regenerative medicine has greatly progressed, but tendon regeneration mechanisms
and robust in vitro tendon differentiation protocols remain to be elucidated. Recently,
tendon explant co-culture (CO) has been proposed as an in vitro model to recapitulate
the microenvironment driving tendon development and regeneration. Here, we explored
standardized protocols for production and storage of bioactive tendon-derived
secretomes with an evaluation of their teno-inductive effects on ovine amniotic epithelial
cells (AECs). Teno-inductive soluble factors were released in culture-conditioned media
(CM) only in response to active communication between tendon explants and stem cells
(CMCO). Unsuccessful tenogenic differentiation in AECs was noted when exposed to CM
collected from tendon explants (CMFT) only, whereas CMCO upregulated SCXB, COL I
and TNMD transcripts, in AECs, alongside stimulation of the development of mature
3D tendon-like structures enriched in TNMD and COL I extracellular matrix proteins.
Furthermore, although the tenogenic effect on AECs was partially inhibited by freezing
CMCO, this effect could be recovered by application of an in vivo-like physiological oxygen
(2% O2) environment during AECs tenogenesis. Therefore, CMCO can be considered as
a waste tissue product with the potential to be used for the development of regenerative
bio-inspired devices to innovate tissue engineering application to tendon differentiation
and healing.
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INTRODUCTION
Tendon differentiation is a stepwise process characterized by the sequential expression of tissue
specific markers, an in vivo occurrence through the interaction of inductive paracrine conditions
and the recruitment of tissue progenitor stem cells (Brent, 2005; Nourissat et al., 2015; Citeroni
et al., 2020). However, a comprehensive determination of the underlying tenogenic differentiation
mechanisms remains elusive. To date, several strategies have been proposed using different stem
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cells sources and techniques, without reaching conclusive results
(Govoni et al., 2017; Dale et al., 2018; Giai Via et al., 2018;
Ciardulli et al., 2020b; Citeroni et al., 2020; Giordano et al., 2020).
The first challenge is the definition of a successful tendon
differentiation process in the absence of consolidated markers.
Indeed, the many genes linked to tendon development are in
common with a wide range of other tissues, including muscle,
bone, and cartilage (Liu et al., 2017). In addition, many of these
genes are already expressed in mesenchyme-derived stem cell
sources (Zarychta-Wiśniewska et al., 2019), making threshold
level determination in tenogensis difficult. The most prevalent
tenogenic markers are Scleraxis (SCX), Tenomodulin (TNMD),
Collagen type I (COL I), Collagen type III (COL III), and
Thrombospondin 4 (THSB4) (Ciardulli et al., 2020b; Citeroni
et al., 2020). The transcription factor SCX is considered an early
marker of tenogenesis, since it is active during development
the early phase of progenitor cell commitment (Schweitzer
et al., 2001; Brent, 2002). COL I and COL III are the major
component of tendon ECM and their modulation is related to
tendon homeostasis and healing (Maffulli et al., 2000; Sharma
and Maffulli, 2005). TNMD and THBS4 are both considered
late tendon markers: TNMD is abundantly expressed in the
mature tissue (Docheva et al., 2005), while THBS4 contributes
to the regulation of extracellular matrix deposition and in
the repair of myotendinous junction (MTJs) (Frolova et al.,
2014; Subramanian and Schilling, 2014). TNMD expression is
positively regulated by SCX (Shukunami et al., 2006), and it is
involved in tenocyte proliferation, aging, and in the formation
of collagen fibrils (Docheva et al., 2005; Alberton et al., 2015).
In fact, mice with loss of TNMD expression showed impaired
tenocyte proliferation, reduced tenocyte density, and increased
maximal and greater variation of fibril diameters (Docheva et al.,
2005).
The partial comprehension of tendon differentiation
underlying mechanisms operating, in particular, during
adulthood has narrowed their exploitation in developing new
cures and in designing innovative tissue engineering (TE)
approaches (Bullough et al., 2008; Andia and Maffulli, 2017;
Migliorini et al., 2020). Poor prognoses are currently related to
tendinopathies as a consequence of the absence of an effective
treatment and the poor spontaneous healing ability of the
tissue from the high degree of specialization leading to a low
cellularity and hypo-vascularity. These conditions appear
responsible for the reparative processes activated in response
to different tendon injuries leading to the formation of scar
tissue (O’Brien, 1997; Sharma and Maffulli, 2005) that negatively
affects tissue functionality. Indeed, tendon injuries remain at the
frontier of advanced responses to health challenges and sectoral
policy targets.
The reduced regenerative property is, however, a peculiarity
of adult tendons. The ability of tendon to regenerate is strictly
age-related (Stalling and Nicoll, 2008): fetal tendons, during
the early and mid-gestational stages, regenerate efficiently after
injuries (Holm-Pedersen and Viidik, 1972). The underlying
mechanism remains to be clarified, but the ability of fetal
tendons to activate regeneration without any scar deposition
appears related to higher levels of fibroblast tendon-related gene
expression (Tang et al., 2015) and to greater local paracrine
activity (Russo et al., 2015). Indeed, elevated levels of key growth
factors and cytokines are implicated in promoting the scarless
phenotype (Liechty et al., 2000; Chen et al., 2005) with cellular
migration and collagen production levels that may support
fetal tendons elevated healing capabilities (Stalling and Nicoll,
2008; Russo et al., 2015). Approaching birth and during the
post-natal lifetime, tendons undergo profound transformations
by progressively losing cellularity and the capability to secrete
growth factors (Ruzzini et al., 2014; Russo et al., 2015). Adult
tendons, becoming differentiated structures, reduce their ability
to activate regeneration process (Sharma and Maffulli, 2005,
2006; Wang, 2006) and, when injured, they repair exclusively
through scar formation (Woo et al., 2000; Fenwick et al., 2002;
Lin et al., 2004).
The hypothesis that alternate paracrine control exists between
adult and fetal tendons is indirectly confirmed from in vitro
experiments. Barboni et al. (2012a) demonstrated that Amniotic
Epithelial Stem Cells (AECs) can be in vitro differentiated toward
tendon-cell lineage when co-cultured with tendon explants
(CO). However, the tendon explant ability in releasing inductive
tenogenic soluble factors are strictly dependent on tendon origin.
Fetal tendon explants were able to drive the differentiation
of ovine AECs more efficiently than adult (Barboni et al.,
2012a), resulting in increased tendon-related gene and protein
expression. Moreover, AECs exposed to fetal tendon explants
acquired a mature tenogenic phenotype organizing themselves
in 3D tendon-like structures (Barboni et al., 2012a). Taking
advantage from such a mechanism, tenogenic commitment was
quickly induced in AECs seeded on an electrospun PLGA
scaffold, increasing their expression of TNMD and COL I gene
and protein (Russo et al., 2020).
This suggests that, similar to other 3D cell culture systems
(Goers et al., 2014; Paschos et al., 2015; Jensen and Teng, 2020),
tendon explants can be successfully exploited to recapitulate
in vitro the dialogue between somatic and progenitor cell
compartments as acted out during fetal tendon development. The
teno-inductive process reported on AECs suggested that fetal
tendon explants were able to activate in vitro the complexity
of paracrine signaling controlling the differentiation and or
regenerative outcomes (Citeroni et al., 2020).
Tendon explant-derived culture approaches may have
different potential impacts. The production of an ex vivo
model to reproduce key differentiation mechanisms (Barboni
et al., 2012a) and the tissue engineering exploitation of a
derived secretome enriched in teno-inductive compounds sit
amongst these.
Starting from these premises, the culture conditions required
to collect teno-inductive secretomes were validated by testing
their biological effect. Indeed, the present research was aimed
to define the differentiation action of conditioned media (CM)
on AECs. In the absence of any molecular characterization, the
process of in vitro tenogenesis was tested on an epithelial stem
cells source and documented by studying tendon differentiation
molecular end points. This rigorous approach has been adopted
to standardize the more suitable protocol to collect teno-
inductive CM and to define the cultural conditions to use
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them after storage. In detail, the first step was to compare the
biological teno-inductive potential of CM collected from the
fetal tendon explant cultured alone (FT) or from AECs co-
cultured with tendon explants (CO) The bio-activity of CM
were tested on AECs by evaluating their in vitro differentiation
by testing late tendon-related genes and proteins expression.
Then, once identified the CM displaying the greater teno-
inductive properties, in the second step, the effects of freezing
storage on CM were defined as in vitro proofs of concept for




AECs cells and fetal tendon explants (FT), used within the
study, were obtained from discarded tissues (fetuses and amniotic
membranes of pregnant slaughterhoused animals) of feed chain
animals by local slaughterhouse. For this reason, no ethic
statements were required.
Experimental Design
The experimental design of this study is summarized in
Figure 1. The first step of the experiment (Figure 1A) was
designed to individuate the cell/tissue culture to maximize the
in vitro release of bioactive secretomes including unknown
teno-inductive soluble factors. To this aim, conditioned media
(CM) were collected either from fetal tendon explants (CMFT)
or from FT in co-culture (CO) with AECs (CMCO) and
successively their biological teno-inductive properties were both
evaluated on AECs. AECs incubated in Standard Media (SM)
were used as a control (CTR) (Figure 1A). The second step
of the experiment was performed to evaluate the impact
of freeze (FZ) storage on the biological properties of CM
(CMFZ) (Figure 1B) by comparing their teno-inductive influence
on AECs with those of freshly isolated CM. Finally, the
teno-inductive properties of CMFZ were also analyzed on
AECs cultured under air or physiological oxygen (physoxia)
(Figure 1B: 21 vs. 2% O2, respectively). All cultures were
maintained for 14 days in standard medium (SM) composed
of α-MEM supplemented with 10% FBS (Gibco), 1 mL/100mL
L-glutamine and antibiotics/antimycotic solution (penicillin G
sodium 100 U/ml, streptomycin 100 mg/ml, amphotericin B 0.25
mg/ml; Gibco, Invitrogen, Carlsbad, CA, USA) or CMs obtained
by different culture conditions, and incubated at 38◦C.
AECs and Tendon Explant Collection
Fetuses of 25–35 cm of length at ∼2–3 months of pregnancy
(Barone and Edagricole, 1983), derived from 6 slaughtered
animals, were used to obtains fetal tendons explants (FT) and
amniotic membrane (AM) to isolate AECs.
AECs were collected as previously described (Canciello et al.,
2018). In detail, the uterus wall was opened to collect AM under
sterile conditions. Then, AM was mechanically peeled from the
chorion with the aid of a stereomicroscope and dissected into 3–
5 cm long fragments. Amnion pieces were washed in Phosphate
Buffered Saline (PBS; Sigma Chemical Co. St. Louis, MO), and
incubated in 0.25% Trypsin/EDTA 200mg /L at 37.5◦C for
20min under gentle agitation. Cell suspensions were collected
after filtration through a 40µmcell filter and poured into a 50mL
Falcon tube, containing 10% Fetal bovine serum (FBS) (Gibco) to
inactivate Trypsin, centrifuged, and the supernatant discarded.
Concentration of vital cells were defined after pellet resuspension
and Trypan Blue staining via a haemocytometer.
AECs were seeded immediately after isolation at a density
of 3,000 cells/well in a 12 well-plate in SM and a flow
cytometry phenotype characterization confirmed via negativity
for haematopoetic markers (CD14, CD58, CD31, and CD45),
positivity for surface adhesion molecules (CD29, CD49f, and
CD166), and stemness markers (TERT, SOX2, OCT4, and
NANOG), low expression for MHC class I molecules, and the
absence of MHC class II (HLA-DR) antigens, as previously
reported (Barboni et al., 2012a,b). FT were isolated from the
forefeet and the peritendineum removed under sterile conditions
(Barboni et al., 2012a). Small pieces of fresh tendon, about 3mm
in size, were isolated, and mechanically disaggregated under a
stereomicroscope with forceps to maximize the interface between
soft tissue and medium. FT explants were washed twice in PBS
with 1% antibiotics and equilibrated in SM at room temperature
(RT) for 10min before transference into an incubator.
Transwell FT and AECs Co-cultures
AECs co-culture (CO) with FT was performed using a transwell
system as previously described (Barboni et al., 2012a). The
AECs were plated onto 12 well-plates at 3,000 cells/well in
SM. Transwell chambers (pore size 0.4µm; Costar, NY, USA),
containing FT explants (n: 2 FT for1 mm3 in size/trans-well),
were inserted into the wells and cultured for FT cultures and
FT+AECs co-cultures, both incubated in air supplemented with
5% CO2 at 38
◦C for 14 days. Each experiments were performed
in triplicate (n = 3 experimental replicates) by comparing cells
derived from 6 different fetuses (n = 6 biological replicates).
The CM were collected at each medium change and processed
as described below.
Conditioned Media Collection, Storage and
Use
CM from co-culture (CMCO) and from FT (CMFT) were collected
every 2 days, centrifuged at 300 × g to eliminate cell debris and
used for further experimentation. Immediately after collection
freshly isolated CMCO and CMFT, were diluted 1:1 in SM (Alves
da Silva et al., 2015) and tested on AECs culture for their
biological teno-inductive influence over 14 days of incubation
(Figure 1A), and compared with the direct effect of CO as well
as with AECs alone incubated in SM (CTR).
The CM tenogenic effect was also tested after freezing. To
this aim, CM were stored from at least 1 month to maximum
3 months at −80◦C (CMFZ). After thawing in 37
◦C bath,
they were used (1:1 dilution in SM) on AECs, and assessed
for their bioactivity in comparison with freshly collected CM.
CMFZ bioactivity was evaluated on AECs incubated in 2% O2
tension, thus mimicking the in vivo physiological condition of
tendon tissue (physoxia) (Benjamin and Ralphs, 1997; Sharma
and Maffulli, 2005; Shukunami et al., 2008) or in air oxygen by
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FIGURE 1 | Experimental design. (A) Analysis of conditioned media (CM) derived from FT alone (CMFT ) and from co-culture system (CMCO) on AECs cultured for 14
days prior to 1:1 dilution with standard media (SM) in air (21% O2) compared with AECs cultured alone (CTR) and in co-culture system (CO: FT+AECs). (B) Analysis of
fresh collected CM after storage at −80◦C (CMFZ) on AECs cultured in either air or and physoxia (2% O2) prior to 1:1 dilution with SM. FT, fetal tendons explants;
AECs, amniotic epithelial stem cells. CO, co-culture with AECs and FT; CMFT, conditioned media of FT; CMCO, conditioned media of CO; CMFZ, CM after freezing
thawing procedure; 21% O2, air oxygen incubator; 2% O2, incubator at 2%; SM, standard media.
using conventional in vitro conditions (air; Figure 1B). In both
the experimental groups, CMFZ were replaced every 2 days. AECs
without CM were used as internal negative control (CTR).
Morphological Evaluation of
Teno-Inductive Effect on AECs
AECs morphology evaluation was performed using inverted
microscopy according to previously described criteria (Barboni
et al., 2012a). In detail, at the end of the culture period, the
structures present in each well of every different experimental
condition were cataloged into three different 3D cell aggregate
types: circular aggregates, elongated structures, and 3D tendon-
like structures. All structures in each well were counted. Data
were obtained at least from six different biological replicates
(n = 6 animals) performed in triplicate (n = 3 experimental
replicates), and reported as the mean± S.D.
Total RNA Isolation and RT-qPCR
Genes related to epithelial mesenchymal transition (EMT),
oxygen signaling response, and tenogenic differentiation were
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VIMa XM_004014247.4 For: 5′-GACCAGCTCACCAACGACA-3′ 93
Rev: 5′-CTCCTCCTGCAACTTCTCCC-3′
SNAILa XM_004014881.2 For:5′- GTCGTGGGTGGAGAGCTTTG−3′ 119
Rev: 5′- TGCTGGAAAGTGAGCTCTGG−3′
TWISTa XM_004008211.4 For: 5′-GCCGGAGACCTAGATGTCATTG-3′ 150
Rev: 5′-CCACGCCCTGTTTCTTTGAAT-3′
TNMDb NM_001099948.1 For: 5′-TGGTGAAGACCTTCACTTTCC-3′ 352
Rev: 5′-TTAAACCCTCCCCAGCATGC-3′
SCXBb XM_866422.2 For: 5′-AACAGCGTGAACACGGCTTTC-3′ 299
Rev: 5′-TTTCTCTGGTTGCTGAGGCAG-3′
COL Ib AF129287.1 For: 5′-CGTGATCTGCGACGAACTTAA-3′ 212
Rev: 5′-GTCCAGGAAGTCCAGGTTGT-3′
COL IIIb AY091605.1 For: 5′-AAGGGCAGGGAACAACTTGAT-3′ 355
Rev: 5′-GTGGGCAAACTGCACAACATT
THSB4b NM_001034728.1 For: 5′-CCGCAGGTCTTTGACCTTCT-3′ 231
Rev: 5′-CAGGTAACGGAGGATGGCTTT-3′
HIF 1α XM_027971913.1 For: 5′-TGCTCATCAGTTGCCACTTC-3′ 311
Rev: 5′-TTTCCTCATGGTCACATGGAT-3′
GAPDHb AF030943.1 For: 5′-CCTGCACCACCAACTGCTTG-3′ 224
Rev: 5′-TTGAGCTCAGGGATGACCTTG-3′
Primers used in aCanciello et al. (2017) and bBarboni et al. (2012a).
examined on whole lysates from AECs isolated after 14 days
of culture in different experimental conditions. SNAIL, TWIST,
and VIM genes were considered as EMT-related markers, HIF
1α to test oxygen signaling response, and SCXB, COL I, COL
III, TNMD, THSB4 as tendon-related genes (see Table 1). AECs
freshly isolated from the membrane immediately stored in liquid
nitrogen (T0) were used as baseline expression control. In
detail, total mRNA was extracted by RNeasy Mini Kit (Qiagen),
according to the manufacturer instructions. Total RNA integrity
was evaluated by 1% agarose gel electrophoresis with GelRed
staining (Biotium). Quantification of total RNA samples was
assessed by using Thermo Scientific NanoDrop 2000c UV-
Vis spectrophotometer at 260 nm. Digestion of genomic DNA
was carried out by DNaseI (Sigma) exposing the samples
for 15min at RT. One step Real-time qPCR analysis was
performed with 10 ng of total mRNA by using SensiFASTTM
SYBR Lo-ROX One step kit (Bioline) and the gene primers in
Table 1. The reactions were carried out with 7500 Fast Real-
time PCR System (Life Technologies) by using the two-step
cycling protocol for 40 cycles (5 s at 95◦C for denaturation and
30 s at 60◦C for annealing/extension) followed by melt-profile
analysis (7500 Software v2.3). For each gene analyzed, each
sample was performed in triplicate, and values were normalized
to endogenous reference gene GAPDH. The relative expression
of different amplicons was calculated by the comparative Ct
(11Ct) method, converted to relative expression ratio (2−11Ct)
(Livak and Schmittgen, 2001), and expressed as fold change over
AECs T0= 1. For primers sequences, see Table 1.
Total Protein Extraction and Western
Blotting
The late tendon marker TNMD and the HIF 1α inducible factor
were both analyzed at protein level by using WB assay. To this








0.5 Anti-mouse HRP conjugated




0.5 Anti-rabbit HRP conjugated
(Santa Cruz sc 2357)
0.04
Mouse HIF 1α (NovusBio
NB 100-123)
2 Anti-mouse HRP conjugated
(Santa Cruz sc 516102)
0.2
aim, total protein was extracted from each sample in lysis buffer
(50mM Tris HCl pH 8, 250mMNaCl, 5mM EDTA, 0,1% Triton
X-100 10%) with Phosphatase Inhibitor (P5726, Sigma) and
Protease Inhibitor Cocktails (P8340, Sigma) diluted according to
manufacturing instruction. Samples were put on ice for 30min,
and then centrifuged at 12,000 × g for 10min at 4◦C. The
supernatant was collected, and 1 µL used to determine protein
concentration with Quick StartTM Bradford 1x Dye Reagent
(BioRad). Afterwards, 30 µg of total protein was separated
by 10% SDS-PAGE, and then transferred to nitrocellulose
membranes (Millipore, Bedford, MA) with TURBO Transfers
(BioRad). Membranes were subsequently incubated with 5%
non-fat dry milk (Sigma) in 0.1% (v/v) Tween 20 in Tris-buffered
saline (T-PBS) for 1 h, at 4◦C. Primary antibodies against mouse-
TNMD, mouse -HIF 1α, and rabbit-αTUBULIN proteins (see
Table 2) were incubated overnight according to manufacturer
instructions. Finally, membranes were incubated with specific
secondary HRP conjugated IgG antibodies for 1 h, at room
temperature. Protein bands were visualized by Euroclone ECL
reagents (LiteAblot PLUS Euroclone EMP011005) and detected
by Azure Byosystem. Densitometric analysis was performed
using Image Lab software (version 4.0, Biorad). Relative protein
expression values were normalized to the corresponding Tubulin
expression. Antibodies details are shown in Table 2.
Immunohistochemistry
TNMD and COL I protein expression and localization were
recorded on in vitro cultured AECs by immunohistochemistry
(IHC). In detail, cells were fixed in 4% paraformaldehyde/PBS
for 10min. After 3X 5min PBS washes, the cells were
permeabilised with 0.1% Triton X-100/PBS for 10min at
RT for TNMD immunostaining, or with Tween 20–0.05%/
BSA 1%/ PBS for COL I immunostaining procedures. Blocking
was performed by incubating cells at RT in PBS/1% BSA
for 1 h. Cells were incubated with rabbit TNMD (10 µg/µL;
Biorbyt, Cambridge, UK) and mouse COL I (10 µg/µl;
EMD Millipore Corporation, Temecula, USA) primary
antibodies overnight at 4◦C. Anti-rabbit Cy3 conjugated
(3.75 µg/µL; Millipore, Temecula, USA) or Anti-mouse
488 FITC conjugated (1 µg/µl; Bethyl, Montgomery, USA)
secondary Abs were then used for 1 h at RT. The omission of
primary antibodies (Abs) were used as negative controls of
reactions. Cell nuclei were identified with DAPI counterstaining.
Morphometric evaluation of the images was obtained using
Axioskop 2 Plus incident light fluorescence microscope
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(Carl Zeiss, Oberkochen, Germany) equipped with a CCD
camera (Axiovision Cam, Carl Zeiss) with a resolution of
1300 × 1030 pixels, configured for fluorescence microscopy,
and interfaced to a computer workstation, provided with
an interactive and automatic image analyser (Axiovision,
Carl Zeiss). For each experimental condition, the reaction
was performed in triplicate (n = 3) on each biological
replicates (n= 6 animals).
Cell Orientation Analysis
Cells orientation of AECs cells after 14 days of culture with
CMCO and CMFZ under air and physoxia condition was
assessed on the obtained 3D tendon-like structures using
the Directionality Plugin of ImageJ (Sensini et al., 2018; El
Khatib et al., 2020), to better determine the teno-inductive
properties of CMs. Briefly, Plugin chops the IHC images
with cells nuclei DAPI counterstained into square pieces and
computes their Fourier power spectra allowing the generation
of statistics data on the basis of the highest peak found
represented by direction (the center of the Gaussian) and
dispersion (the standard deviation of the Gaussian). Images
of healthy tendon explants were used as internal control to
establish the reference values for the analyses. This approach
quantifies the cells direction, dispersion, and amount (the
sum of the histogram from center-S.D. to center ± S.D,
divided by the total sum of the histogram). The real histogram
values are used for the summation, not the Gaussian fit
(amount). A direction of 0 degree means that the cells are
oriented with the longitudinal axis of the sample. The higher
is the dispersion value, the lower is the homogeneity of
cells orientation.
Statistical analyses were performed by One Way ANOVA and
expressed as means ± S.D of six biological replicates (n = 6
animals)/each experimental condition in triplicate.
FIGURE 2 | (A) Representative images of different cell aggregates developed by AEC cultured under CTR and different teno-inductive (CO and CM) cultural
conditions. Images were obtained with Olympus microscope IX-50 and processed with Image-Pro Insight software. Magnification 10X, scale bar 100µm. (B)
Representative immunofluorescent images displaying the main cell organization after 14 days of culture as CTR, CO, CMCO. and CMFT, respectively. AEC under CTR
condition after 14 days lead a confluent monolayer negative for both COL I and TNMD. On the contrary, CO, CMCO, and CMFT promote formation of COL I and TNMD
positive 3D structures even if only in CO and CMCO both the proteins reach a high concentration combined with an extracellular localization. Representative IHC
images of COL I (green color) and TNMD (red color) protein expression in AECs after 14 days of culture under different experimental conditions. Nuclei were
counterstained with DAPI (blue color). Magnification 20X, scale bar: 100µm.
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Statistical Analysis
The quantitative data of the analysis were obtained by analyzing
at least three samples for each experimental condition performed
in triplicate (n= 3) on each biological replicates (n= 6 animals).
The RT-qPCR results were firstly assessed for distribution using
Shapiro Wilks test. Data sets were compared using Kruskal-
Wallis test followed by Dunn’s post hoc test. The quantitative data
for morphological structures, WB analysis and cells orientation,
were expressed as mean ± S.D by using One Way ANOVA
followed by Tukey post hoc test (GraphPad Prism 6, GraphPad
Software, San Diego, CA, USA). Significant was set at p < 0.05.
RESULTS
CMCO Displayed an Enhanced
Teno-Inductive Influence on AECs
CM derived from FT (CMFT) and CO (CMCO) were evaluated in
their biological teno-induction capacity on AECs differentiation
into tendon lineage over 14 days of culture. Specifically, AECs,
following on from incubation, may acquire different phenotypes
ranging from a persistent planar, monolayer, organization to
3D cellular aggregates with circular or elongated structures
and ultimately tendon-like units. When AECs are exposed
to CM, they first assumed a sheet monolayer in few days
before spontaneously forming cell clusters. Sometimes they
developed circular aggregates, randomly distributed within the
well, which, at the end of the incubation period, may morph into
elongated structures with different degree of organization. The
more complex elongated structures acquired a 3D architecture,
at the end of incubation, by detaching from the monolayer
substratum and maintaining peripheral contacts with the well-
border, becoming 3D tendon-like units at day 14. The 3D
tendon-like structures reached a final size ranging from 0.4
to 2mm in length without any difference amongst the groups
(data not shown). These main AEC phenotypes obtained during
the 14 days of culture, are represented in Figure 2A. CMCO
displayed a higher ability to promote an AECs morphology shift
toward 3D tendon-like structure organization accordingly to
the incidence of 3D tendon-like structures (Table 3) and their
proteins composition (Figure 2B).
The highest prevalence of 3D tendon-like structures was
recorded in AECs exposed to CO and in CMCO (both p < 0.05
vs. CMFT). Conversely, CMFT induced in AECs a significant high
percentage of circular aggregates (p < 0.05 vs. CO and CMCO,
respectively) and elongated structures (p < 0.05 vs. CO).
In this experimental phase, IHC was carried out in order to
evaluate the presence and localization of COL I and TNMD
tenogenic proteins, representing end point signals of tendon
like cells.
Exclusively CO, CMCO and were able to switched on the
expression of COL I and TNMD that is absent in freshly isolated
AEC (data not shown) and in AEC cultured for 14 days under
CTR condition. However, IHC results indicated that the process
of teno-differentiation was more evident in both CO and CMCO
(Figure 2B) where both COL I and TNMD seem to reach higher
levels of expression but, above all, they did not have an exclusive
TABLE 3 | CMCO promotes the formation of elongated and tendon-like structures.
Culture
conditions







CTR 0 0 0
CO 0 2 ± 0.53* 11 ± 0.83*bc
CMCO 0 3 ± 0.71* 8 ± 0.86*
c
CMFT 6 ± 0.98*
ab 4 ± 0.75*a 2 ± 0.78*
Number of 3D cells structures counted in different experimental conditions and expressed
as the mean ± S.D obtained by analyzing 12 well/ experimental group for each animal (n
= 6). Data were analyzed by One Way ANOVA Test followed by Tuckey post hoc test.
Statistics was performed on the same typology of structure between the experimental
groups. Values were considered statistically significant for p < 0.05 for superscript *vs.
CTR; avs. CO; bvs. CMCO;
cvs. CMFT .
cytoplasmic localization but also they appeared as a components
of extracellular matrix.
In fact, AECs exposed to CO or to CMCO revealed an
advanced cellular and extracellular matrix (ECM) in the 3D
structures. The tendon-related phenotype changes, at both
morphological and molecular levels, were promoted in epithelial
cells derived from amniotic membrane exclusively in response to
inductive cultural conditions. Indeed, AECs did not express COL
I and TNMD either immediately after isolation (data not shown)
or at the end of culture when they were maintained under CTR
conditions (Figure 2B). Instead, COL I appeared in 3D circular
aggregates (data not shown) while TNMDwas mainly in tendon-
like structures (Figure 2B). The qualitative expression of both
the proteins was, particularly, elevated in CO and CMCO derived
3D tendon-like structures, when COL I and TNMD proteins
were mostly localized along the 3D structures and not in the
other dispersed cells (Figure 2B). In addition, the 3D tendon-like
structures of CO and CMCO showed a more advanced tendon-
like organization with elongated cells displaying nuclei mainly
oriented along the major axis of the in vitro developed tissue
units (Figure 2B, CO and CMCO). By contrast, the 3D tendon-
like structures induced by CMFT (Figure 2B, CMFT) were thinner
with a lesser degree of tissue organization and faint fluorescent
signal revealing weak expression of COL I and TNMDprincipally
expressed at an intracellular level (Figure 2B, CMFT).
The tendon-like AECs differentiation outcome induced by
CMCO was confirmed by gene expression analysis (Figure 3).
Tendon-related gene expression was predominantly upregulated
in CO and CMCO treated-samples, while CMFT mainly induced
overexpression of EMT-linked transcripts (Figures 3A,B). In
detail, CMFT displayed a limited up-regulatory influence on
EMT transcription factor TWIST (p < 0.05 vs. CTR, CO, and
CMCO) and EMT endpoint marker VIM (p < 0.05 vs. CTR,
CO, and CMCO) and two tendon-related genes SCXB and COL
I (both p < 0.05 vs. CTR) (Figure 4B). On the contrary, a
more advanced tendon expression profile was observed in AECs
exposed to CO and CMCO. The early and late tendon-related
genes, SCXB and THSB4 and TNMD, respectively, showed a
significant upregulation in AECs under both CO and CMCO
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FIGURE 3 | CMCO promotes upregulation of tendon-linked gene expression. Gene expression profile by Real time qPCR analysis of (A) EMT genes and (B) tendon
related genes in AECs cells cultured for 14 days in different experimental conditions. Relative quantification of each mRNA gene expression normalized to endogenous
GAPDH (internal control) was calculated using the 11Ct method and expressed as fold change over the AECs T0 =1 (calibrator; dashed line). Values were
considered significant for p < 0.05, with the indicated superscripts *vs. CTR, avs. CO, bvs. CMCO,
cvs. CMFT, respectively.
conditions (both p < 0.05 vs. CMFT) while COL III reached the
highest levels of expression in CMCO-treated AECs (p < 0.05 vs.
CO and CMFT) (Figure 3B).
According to the biological responses, of both genes profile
expression and morphological phenotype, induced in vitro
on AECs by the derived secretomes, CMCO was selected
for its higher teno-inductive performance and used for the
following experiments.
Freezing Reduced the Tenogenic Induced
Activities of CMCO
To extend the impact of CMCO on in vitro tenogenesis and
in cell-free regenerative medicine innovation, the viability of
CMCO storage by freezing was evaluated. The teno-inductive
potential of CMCO stored at −80
◦C (CMCOFZ) was compared
with those of CO and freshly collected CMCO in their effect on
in vitro AECs tendon differentiation (Figure 1B). A reduction
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FIGURE 4 | Evaluation of tenogenic potential CMCOFZ on AECs after 14 days of culture. (A) Real time qPCR analysis for SCXB, COL I, and TNMD tendon related
genes in AECs cells cultured for 14 days in different experimental conditions. Relative quantification of each mRNA gene expression normalized to endogenous
GAPDH (internal control) was calculated using the 11Ct method and presented as fold change over the AECs T0 =1 (calibrator; dashed line). Values were considered
significant when p < 0.05, with superscripts *vs. CTR, avs. CO, #vs. CMCOFZ. (B) Representative Western Blot image for α-TNMD and α-TUBULIN proteins
expression on different experimental conditions. (C) α-TNMD protein quantification normalized on α-TUBULIN expression levels and expressed as means ± S.D of
three replicates/each experimental condition. Values were considered significant when p<0.05, with the indicated superscripts *vs. CTR, #vs. CMCOFZ,
£vs. T0. (D)
Representative IHC images for COL I (green color) and TNMD (red color) protein expression in AECs after 14 days of culture under CMCOFZ experimental condition.
Nuclei were counterstained with DAPI (blue color). Magnification 20X, scale bar: 100µm.
in the tendon-inductive action of CMCOFZ was suggested by the
morphological outcomes of the in vitro cultures (Table 4 and
Figure 4D) and confirmed by the tendon-related gene profiles
(Figure 4A), respectively. AECs treated with CMCOFZ displayed
a reduced ability to induce the development of 3D structures (p
< 0.05 vs. both CO and CMCO). AECs in CMCOFZ aggregated
mainly circular (p < 0.05 vs. both CO and CMCOFZ) and
elongated structures (p < 0.05 vs. CO and CMCO) with a limited
number of 3D structures that reached the tendon-like stage
(Table 4).
The gene profile of AECs exposed to CMCOFZ confirmed their
reduced stage of tendon differentiation. Indeed, the CMCOFZ
induced AECs showed upregulation exclusively of SCXB and
COL I that reached expression levels similar to those recorded
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 9 March 2021 | Volume 9 | Article 649288
Citeroni et al. Amnion Derived Secretomes to Foster Tenogenesis
TABLE 4 | CMCOFZ has a reduced teno-inductive capacity.
Culture
conditions







CTR 0 0 0
CO 0 2.5 ± 0.53* 12 ± 0.83*b#
CMCO 0 2.6 ± 0.71* 7.5 ± 0.86*
#
CMCOFZ 4 ± 0.98*
ab 5.5 ± 0.75*ab 3 ± 0.78*
Number of 3D cells structures counted in different experimental condition and expressed
as the mean ± S.D obtained by analyzing 12 well/ experimental group for each animal
(n = 6). Data were analyzed by One Way ANOVA Test followed by Tuckey post hoc test.
Statistics was performed on the same typology of structure between the experimental
groups. Values were considered statistically significant for p < 0.05 for superscript *vs.
CTR, avs. CO, bvs. CMCO,
#vs. CMCOFZ .
under CO and CMCO conditions (p< 0.05 vs. CTR). By contrast,
the late marker of tenogenesis TNMD never reached the levels
recorded in CO and CMCO structures (for both p < 0.05;
Figure 4A). The IHC analysis (Figure 4D) revealed that the rare
3D tendon-like structures obtained under CMCOFZ condition
displayed the positivity for both COL I and TNMD proteins
involving either the intracellular or extracellular distribution
(Figure 4D). However, the protein content quantified by using
Western Blot analysis (Figures 4B,C), confirmed a significant
TNMD protein levels reduction in CMCOFZ respect to CO and
CMCO (for both p < 0.05), even if it was overexpressed respect to
the CTR and T0 samples (for both p < 0.05) (Figure 4C).
Physoxia Restored the Tenogenic Potential
of Frozen Co-culture Conditioned Media
The culture in 2% O2 was able to influence the phenotype of
AECs and to enhance the teno-inductive action of CMCOFZ. The
effect of O2 tension on AECs cultures was confirmed by the
expression of the physoxia marker HIF 1α analyzed at gene and
protein level (Figure 5). More in detail, the expression HIF 1α
were significantly downregulated in samples under physoxia (p
< 0.05 both CTR 2% and CMCOFZ 2% vs. CTR and CMCOFZ)
(Figure 5A). Where, on the contrary, a significant higher levels
of HIF 1α protein was detected (p < 0.05 of both CTR 2% and
CMCOFZ 2% vs. CTR and CMCOFZ) (Figures 5B,C).
Chronic exposure of AECs to physoxia had an interestingly
effect on their phenotype (see Table 5). In particular, physoxia
increased the ability of AECs exposed to CMCOFZ to develop in
vitro 3D tendon-like structures (p < 0.05 of CMCOFZ in 2% O2
vs. CMCOFZ) (Table 5).
The EMT gene-related profiles were downregulated in cells
incubated under 2% O2 tension involving SNAIL, TWIST, and
VIM (p < 0.05 for both CTR 2% vs. CTR and CMCOFZ 2%, vs.
CMCOFZ) (Figure 6A). On the contrary, physoxia induced the
upregulation of tendon-related genes: CTR overexpressed COL
I (p < 0.05 CTR vs. CTR 2%) (Figure 6B), whereas CMCOFZ
2% overexpressed both the early and late markers, SCXB and
TNMD, respectively (for both p< 0.05 CMCOFZ 2% vs. CMCOFZ)
(Figure 6B).
The protein quantification of TNMD reinforced the evidence
of the stimulatory influence of 2%, O2 in promoting tendon
differentiation in AECs (Figures 6C,D). Indeed, AECs cultured
under physoxia conditions displayed significantly higher levels
of TNMD (p < 0.05 CTR vs. CTR 2%), reaching values similar
to those induced in AECs from CMCOFZ exposure (p > 0.05
CTR 2% vs. CMCOFZ in 21% O2). The intracellular TNMD levels
were further significantly increased when AECs were exposed to
the tendon inductive influence of 2% O2 in combination with
the stimulatory action of CMCOFZ (p < 0.05 CMCOFZ 2% vs.
CMCOFZ) (Figures 6C,D).
Both COL I (green fluorescence in Figure 7) and TNMD (red
fluorescence in Figure 7) proteins were localized in 3D tendon-
like structures developed in vitro from AECs exposed for 14 days
to CMCOFZ and CMCOFZ 2%. Weak positivity was observed also
in CTR AECs incubated under physoxia condition (CTR 2%),
independently from their ability to aggregate and develop 3D cell
structures (Figure 7).
Altogether, these results suggested that physoxia can
enhance the AECs response to the teno-inductive properties of
frozen CMCO.
AECs’ Alignment Induced by CMCO and
CMCOFZ 2% Confirmed the Greater
Specialization of 3D Tendon-Like Derived
Structures
CMCO and low levels of O2 pressure were also able to impact
on the quality of the 3D tendon-like structures developed
after 14 days of culture by influencing AECs orientation and
alignment (Figure 8). Indeed, according to the Fourier power
spectra analyses obtained by the Directionality Plugin of ImageJ
schematized in Figure 8A, the qualitative distribution of cell
angle direction exposed to CMCO, and CMCOFZ 2% described
a Gaussian curve with a tight shape similar to that recorded
in healthy tendon (Figure 8B). On the contrary, both CTR
(2 and 21% O2) groups developed randomly oriented cells as
demonstrated by the pronounced flattening shape of Gaussian
curve (Figure 8B). The cells treated with CMCOFZ expressed
an intermediate behavior (Figure 8B). Even though the global
analysis of angle direction did not reveal any significant
differences among the groups as a consequence of its great
individual variation (Figure 8C, p > 0.05), the dispersion values
which report the standard deviation of the Gaussian curves
confirmed the similarity amongst CMCO and CMCOFZ 2% and
healthy tendon in respect to CMCOFZ (Figure 8D, p < 0.05).
DISCUSSION
This study aims to evaluate the biological effect of CM secretome
derived from ovine tendon fetal tissue, in order to propose a
new approach able to promote teno-differentiation for veterinary
and medical purposes. Tissue co-culture provides a favorable
microenvironment for the induction of in vitro tissue specific
differentiation (Paschos et al., 2015; Xie et al., 2018; Chu
et al., 2020). This approach has been successfully applied to
in vitro tenogenesis (Barboni et al., 2012a), being effective in
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FIGURE 5 | Physoxia effects of tenogenic potential of CMCOFZ on AECs after 14 days of culture. (A) Real time qPCR analysis for HIF 1α expression in normoxia CTR
and CMCOFZ and in physoxia CTR 2% and CMCOFZ 2% conditions. Relative quantification of each mRNA gene expression normalized to endogenous GAPDH (internal
control) was calculated using the 11Ct method and presented as fold change over the AECs T0 =1 (calibrator; dashed line). (B) Representative Western Blot image
for HIF 1α and α-TUBULIN proteins expression on different experimental conditions. (C) HIF 1α protein quantification normalized on α-TUBULIN expression levels and




TABLE 5 | Physoxia recovers CMCOFZ teno-inductive capacity.
Culture
conditions







CTR 0 0 0
CMCOFZ 2.5 ± 0.96
*@ 5 ± 0.22*§@ 4.5 ± 0.65*§
CTR 2% 3 ± 0.89*@ 2 ± 0.75* 0
CMCOFZ 2% 1 ± 0.54 3 ± 0.77* 6.5 ± 0.72
*#§
Number of 3D cells structures counted in different experimental condition and expressed
as the mean ± S.D obtained by analyzing 12 well/ experimental group for each animal
(n = 6). Data were analyzed by One Way ANOVA Test followed by Tuckey post hoc test.
Statistics was performed on the same typology of structure between the experimental
groups. Values were considered statistically significant when p < 0.05 for superscript
* vs. CTR, #vs. CMCOFZ ,
§vs. CTR 2% @vs. CMCOFZ 2%.
enabling a stepwise differentiation process in freshly isolated
amniotic epithelial cells (AECs). The soluble factors released
from tendon explants first drove the freshly isolated AECs
toward the mesenchyme phenotype followed by a tendon-
like three dimensional organizations which expressed tissue
specific markers (Barboni et al., 2012a). Tendon differentiation
is represented by a complex biological process characterized
by the orchestration of multiple mechanisms including the
sequential expression of early and late markers such as SCXB
and TNMD, respectively (Schweitzer et al., 2001; Docheva et al.,
2005; Dex et al., 2017; Citeroni et al., 2020). In particular,
TNMD is generally accepted as structural and functional marker
of the mature tendon lineage differentiation (Citeroni et al.,
2020). Given its complexity, tenogenesis is hard to achieve,
especially in vitro, and to date the biological processes and
signaling involved are as yet largely unknown. Several teno-
inductive techniques are proposed, involving the use of growth
factors, biomimetic materials and/or bioreactor, but none of
these methods is considered robust in predictably induce a fully
committed tendon phenotype (Citeroni et al., 2020). Here, the
culture condition for collection of teno-inductive secretomes
from tendon explant and AECs co-culture has been defined.
These confirmed that teno-induction did not require cell-to-
cell interaction, but was achievable through the stimulatory
influence of bioactive factors released into the culture media
(CM). This provides a powerful strategy for the small scale
production of inductive factors sufficient to drive a complete
tenogenic differentiation. In addition, AECs proved to be an
useful stem cell model for the study of in vitro tenogenesis and
to test the teno-inductive properties of different stimuli such as
different typologies of CM. Starting from an epithelial phenotype,
the process of tenogenesis can be documented strictly through
the switch on of molecules that are not expressed into freshly
derived primary epithelial cells and not from an expression level
consistent with a mesenchyme stem cell source (Dai et al., 2015;
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FIGURE 6 | Evaluation of tenogenic potential of CMCOFZ 2%. Real time qPCR analysis for (A) EMT genes and (B) tendon related genes on samples in AECs cells
cultured for 14 days in different experimental conditions. Relative quantification of each mRNA gene expression normalized to endogenous GAPDH (internal control)
was calculated using the 11Ct method and presented as fold change over the AECs T0 =1 (calibrator; dashed line). (C) Representative Western Blot image for
α-TNMD and α-TUBULIN proteins expression. (D) α-TNMD protein quantification normalized on α-TUBULIN expression levels and expressed as means ± S.D of three
replicates/each experimental condition. Values were considered significant for p < 0.05, with the indicated superscripts *vs. CTR, #vs. CMCOFZ,
§vs. CTR 2%, £vs. T0.
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FIGURE 7 | Representative IHC images of COL I (green color) and TNMD (red color) proteins expression in AECs under normoxia and physoxia experimental
conditions. Nuclei were counterstained with DAPI (blue color). Magnification 20X, scale bar: 100µm.
Ciardulli et al., 2020a). Indeed, the biological response of AECs to
CM allowed documentation of distinct bioactivity properties by
identifying the greater teno-inductivity of supernatants derived
from the co-cultures (CMCO) between fetal explants and AECs.
Soluble factors accumulated in CMCO displayed a higher ability
to promote an AECs phenotype shift through the organization of
3D tendon-like structures that displayed a transcriptional profile
characterized by simultaneous EMT and tendon-related gene
upregulation (SNAIL, VIM and SCXB, COL III, COL I, TNMD,
THSB4, respectively). Furthermore, the final commitment of
AECs toward tendon lineage was strongly confirmed by COL
I and TNMD proteins that were largely localized in AECs
composing the CMCO derived 3D tendon-like structures in
contrast to the AECs incubated under CTR conditions. The
teno-inductive factors were released into supernatants of the co-
cultures, thus indicating that an active in vitro dialogue between
AECs and tendon explants was specifically triggered.
Even if soluble factors released in the CM were not
characterized, the in vitro results showed that an epithelial source
of stem cells that does not express any tendon-related protein,
were induced to respond to soluble factors released into CM in
response to the mutual dialogue between fetal tendon tissue and
amniotic derived cells.
The differentiation process induced in AEC had been repeated
by reaching consistently tendon lineage genome and protein
end point. The biological efficacy of CM balanced out the
absence of information about the molecular composition of these
secretomes that will required time in order to identified the
cocktail of factors involved in an animal model such as sheep,
where the molecular codification reached to date is very limited.
This is complicated by the large molecular classes that have been
described to be involved in teno-induction belonging to lipid,
protein and miRNA classes (Citeroni et al., 2020).
Previously in vitro and in vivo evidences clearly supported the
ability of AECs in receiving tenogenic inductive information in
response to specific stimuli coming from co-culture with tenocyte
of different species or from injured host tendons (Muttini et al.,
2018). This information was obtained by adopting different
in vivo approaches by transplanting ovine AEC under either
allograft or xenograft settings (Barboni et al., 2012b; Muttini
et al., 2013, 2015, 2018; Mauro et al., 2016).
The xenotransplantation in vivo model open, in addition, the
scenario to use the ovine derived secretomes also for inducing
tenogenesis in other mammals’ species. Indeed, by analyzing
the genome response of human AEC transplanted into an
ovine injured, this concept was confirmed since human AECs
xenotransplanted actively dialogued with the host tissue by
upregulating several genes involved, at the same time, in tendon
regeneration, angiogenesis, and immune response (Barboni et al.,
2018).
Moreover, these results strongly suggest that CM
secretome could be positively considered in trans-species
translational medicine.
On the contrary, CM collected exclusively from fetal tendon
explants alone (CMFT), were more effective in inducing
EMT than tenogenesis. This conclusion is supported by the
overexpression by AECs of EMT transcription factor gene
TWIST and the mesenchyme final marker VIM, as well
as by their failure to upregulate TNMD. Not surprisingly,
AECs exposed to CMFT developed a very limited number
of 3D tendon-like structures at the end of incubation when
compared to CO and CMCO. Moreover, TNMD protein levels,
detected by Western Blot analysis, were significantly reduced
respect to CO and CMCO. These results indicated that tendon
explants alone were not able to generate per se factors able
to recapitulate a complete tenogenic differentiation, whereas
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FIGURE 8 | Directionality analyses on AECs cells orientation in 3D tendon-like structures under different culture conditions. (A) Representative scheme of the
Directionality Plugin used to analyse cells orientation within the different treated groups. (B) Representative Gaussian graphs [X = Cells Orientation (◦), Y = Pixel
Amount (%)]. Analysis of (C) angle direction (cells orientation calculated on the bases of the longitudinal axis of the sample) and (D) angle dispersion (the standard
deviation of the Gaussian). Healthy tendon was used as reference sample for the analyses. Statistical analyses were performed by One Way ANOVA and expressed as
means ± S.D of six biological replicates (n = 6 animals) for each experimental condition performed in triplicate. Values were considered significant for p < 0.05, with
the indicated superscript #vs. CMCOFZ.
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they release bioactive molecules driving EMT as a culture
end point.
In the absence of validated markers indicative of tenogenesis,
in the present study teno-induction was confirmed by
complementarity of gene, protein and morphometric data.
The gene and protein profile are relevant, since both early and
late tendon-related genes were low or absent in AECs cultured
in the absence of any inductive stimulus. The morphological/
morphometric analysis of AECs revealed that tendon-like
structures were achieved in response to an active process
driven by CO or by the AECs exposure to CMCO. On the
contrary, AECs under CTR condition did not aggregate or
align in 3D structures, instead maintaining the native epithelial
phenotype. These results defined, for the first time, the protocol
for small-scale production of teno-inductive soluble factors
while simultaneously validating in vitro AECs culture as a tool
for bioactivity assay.
The availability of tendon-inductive factors may have research
and application impacts in both helping establish robust in vitro
tendon differentiation protocols and facilitating the development
of tendon tissue engineering approaches. The availability of
bioactive CM with defined teno-inductive properties may be
applied to either scaffold functionalisation (Burdette et al.,
2018; Chen et al., 2021) or in nanoparticle generation (Felice
et al., 2018), both of which may have a clinically relevant role
in the development of a new therapies for tendon pathology
(Daneshmandi et al., 2020; Rhatomy et al., 2020).
Tissue engineering protocols directed toward tendinopathies
(Andia and Maffulli, 2019) will require that the CMCO secretome
drive signaling in a low oxygen environment which, in tendons, is
physiological. In fact, tendon exists in a low oxygen milieu given
the poor vascularisation of the tissue (Benjamin and Ralphs,
1997).While skeletal muscle oxygenation is estimated to be 2–5%
O2, the oxygen consumption of tendons and ligaments is likely
7.5 times lower (Sharma and Maffulli, 2005). This means that
tenocytes live in a physiological lowO2 environment (Shukunami
et al., 2008). Low oxygen pressure is required, alongside specific
growth factors, to induce tendon differentiation in embryonic
stem cells (Dale et al., 2018) and, in combination with others
stimuli, in mesenchymal stem cells (Yu et al., 2016; Zheng
et al., 2017). Regarding this particular aspect, the present study
demonstrated, using AECs, that low oxygen (physoxia, 2% O2)
is a permissive condition enabling AECs to EMT. Low oxygen
has been established as a regulator of EMT in pathological
processes such as tumorigenesis (Chen and Wu, 2016) of breast
(De Francesco et al., 2018), prostate (Tang et al., 2019), and lung
cancer (Kohnoh et al., 2016), or in mesothelial cells triggering
peritoneal fibrosis formation (Morishita et al., 2016). However,
EMT is a biological process associated not only with pathological
conditions, but also with physiological processes which take
place during embryonic development, morphogenesis and stem
cells differentiation (Chen et al., 2017). Moreover, EMT was
recently demonstrated to be involved in Achilles tendon repair
in rats model (Sugg et al., 2014). Intriguingly, the present results
demonstrated that physoxia can be exploited to overcome the
negative effect of freezing on the teno-inductivity of CMCOFZ.
Working upwards from a baseline principle that CMCO storage
is an unavoidable procedure to allow its future, off-the-shelf,
widespread application, the effect of freezing has been analyzed.
Storage at −80◦C partially affected the teno-inductive potential
of CMCO. Indeed, despite no differences in SCXB and COL
I mRNA content, the expression of the late tendon marker
TNMD was significantly decreased in AECs exposed to CMCOFZ
with respect to CMCO, even though its level was maintained
over CTR. These data suggested that CMCOFZ was able to start
the tenogenic process in AECs, but was unable to achieve the
differentiation end point. Indeed, CMCOFZ resulted in a reduced
formation of 3D tendon-like structures which, however, were
positive for COL I and TNMD protein expression. Conversely,
CMCOFZ when combined with a physoxic environment enhanced
AECs differentiation and stimulated elevated expression of early,
SCXB, and late TNMD, markers at both mRNA and protein
levels. Biological data (gene expression and protein distribution)
combined with morphological results, obtained in AECs exposed
to CMCOFZ under physoxia, suggested that cryogenic storage did
not switch off the teno-inductive molecules secreted but, it could
modify their availability and or/concentration. Physoxic culture
could enhanced the capacity of AECs to respond to the molecular
tenogenic factors present in frozen CMCO, as demonstrated by
the 3D structures that reached morphological and biochemical
levels similar to those recorded in healthy tendons and in
CMCO treatment. Moreover, directionality analysis confirmed
the differences in cells angle dispersion between CMCO and
CMCOFZ 2% respect to CMCOFZ. The hypothesis that low
oxygen can be the most suitable culture condition to induce
tenogenesis, is also supported by TNMD upregulation in AECs
under physoxic condition (CTR 2%) observed in this study.
According to our results, enhanced TNMD expression was
demonstrated in human embryonic stem cells (hESCs) under
low oxygen culture without any further stimulation (Dale et al.,
2018). The Authors indicated that 2% O2 supplemented with a
cocktail of bone morphogenetic protein-12,−13 (BMP-12, BMP-
13), and ascorbic acid (AA) represented the best culture system
to induce tenogenesis in hESCs (Dale et al., 2018). According to
this literature data, physoxia, the natural environment of stem
cells niche (Mohyeldin et al., 2010) and also of amniotic stem
cells (Johnell et al., 1971; Banerjee et al., 2018), can enhance
tendon differentiation biological response as demonstrated for
adipose-derived mesenchymal stem cells (Yu et al., 2016) and for
menstrual blood stromal stem cells (Zheng et al., 2017).
Even if, in the absence of a complete molecular
characterization and without any evidence supporting the
cell-to cell communication mechanisms involved, several
evidences confirmed the biological role of CM derived from
amniotic cells under in vitro and in vivo conditions (Rossi
et al., 2012; Lange-Consiglio et al., 2013a). More in detail, the
CM-derived from amniotic stem cells were recently used in
vivo to improve clinical recovery in spontaneous tendinopathies
in 13 horses (Lange-Consiglio et al., 2013a). This manuscript
confirmed the idea that, even in the absence of any molecular
characterization, the strong biological outcome obtained can
be indirectly used to confirm that AEC may have a positive
role in inducing tendon regeneration adopting a paracrine
action (Barboni et al., 2012b, 2018; Lange-Consiglio et al.,
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2013b; Muttini et al., 2013, 2015, 2018). However, any practical
application of such cells derivates, however, pass through the
possibility to preserve their biological influence unaltered
over time.
Long term storage technologies of bio-derivate compounds
are available and could be tested under strict experimental
conditions to evaluate their efficacy. Lyophilisation removes
water from frozen samples by sublimation and desorption in a
vacuum (Chen et al., 2010), and it is used to preserve biological
materials such as proteins (Roy andGupta, 2004; Jain et al., 2019),
plasma (Jennings et al., 2015; Storch et al., 2019), and also living
cells (Keskintepe and Eroglu, 2015). Moreover, lyophilisation
improved the long-term stability of nanosized drug delivery, such
as liposomes (Liu et al., 2015) and exosomes (Charoenviriyakul
et al., 2018). It was also demonstrated as a solution to preserve
the whole secretome (Fernandes-Cunha et al., 2019; Chen et al.,
2021).
Lyophilisation, even though not been performed yet in
this setting, could be explored for utility in preservation
of CMCO. There could be several advantages of the use
of tenogenic secretome obtained with this strategy in the
field of regenerative medicine. The use of the CM secretome
has advantages over the implantation of the stem cells
themselves, as their components, such as extracellular vesicles,
liposomes, growth factors, and miRNA can be bioengineered
and scaled to specific dosages, and the cell-free nature of the
secretome enables it to be efficiently stored and transported.
The CMCO secretome could be used to produce enriched
nanodevices for tendon tissue regeneration. According to
the use of secretome for tissue regeneration, Felice et al.
(2018) demonstrated that nanoparticles loaded with endothelial
progenitor cell (EPC) secretome contributed to ischemic tissue
repair by controlled paracrine secretion upregulated by hypoxia.
Secretome charged nanoparticles could be advantageous as the
technique allows close spatiotemporal control on the kinetic
release of the CM (Felice et al., 2018), and could be used to
directly inject local focal lesions or to functionalise scaffolds
(Tang et al., 2017; Shoma Suresh et al., 2020; Chen et al.,
2021).
The composition of nanoparticles themselves is to be taken
into account to elaborate appropriate storage conditions, and
it must be functional to the intended use. Furthermore, both
nanovescicles or nanobeads can be chosen to reach this goals, and
both can ensure a controlled or targeted delivery of their payload,
respectively, as recently suggested (Ciaglia et al., 2019; Palazzo
et al., 2021). On the other hand, the main component of the CM
has to be investigated to study the kinetic of the release (Felice
et al., 2018).
In the future, the characterization of CMCO secretome will be
pursued to identify which molecular combination is involved in
inducing tenogenesis.
This will be a great attainment either to solve an open
challenges of veterinary and medicine tissue engineering or to
take advantage of nanomedicine technologies (pharmacokinetic
studies and storage protocols) to use teno-inductive secretomes
for scaffolds functionalisation.
Even though an epithelial stem cell source was used as proof of
concept to confirm the teno-inductive properties of CMCO before
proposing them as a novel therapeutic biological cell-free product
to support tendon regeneration, their validation on other stem
cell sources derived from species of vet and medicine relevance
or on in vivo settings have to be considered before moving their
use toward clinical applications.
CONCLUSION
In conclusion, the major goal of the present study was the
definition of an in vitro protocol for the collection of bioactive
teno-inductive factors (CMCO) and to preserve them over
time. A small scale production of validated teno-inductive
supernatants may have a great impact for research and for
developing TE to restore tendon microarchitecture and function.
Indeed, the proposed in vitro system that models tenogenesis
by recapitulating the native paracrine phenotypic patterns may
result in significant advances in tendon biology and tenogenic
phenomena at the cellular and molecular levels. At the same
time, the availability of low-cost bioactive factors with assayable
teno-inductive properties in combination with the progress
of biomedical technologies (nanomedicine and scaffold design
and fabrications) may provide practical answer and sustainable
solution to establish cells free therapies protocols by innovating
the challenging field of tendon medicine.
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